400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Immunology/Inflammation / LTR / 扎鲁斯特
CAS No.: 107753-78-6
Synonyms: ICI 204219;ICI-204,219;brand names Accolate
Zafirlukast is the first-approved LTR antagonist with anti-asthmatic and potential capsular contracture-preventing activities.
生物活性
动物研究 | |
剂量 | Rat: 40 mg/kg, 80 mg/kg[3] (p.o.) |
给药途径 | p.o. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01125748 | Allergic Asthma | Phase 4 | Completed | - | - |
NCT01125748 | - | - | Completed | - | - |
NCT01283061 | Healthy | Phase 1 | Completed | - | India ... more >> BA Research India Ltd. Ahmedabad, Bodakdev, India, 380 054 Collapse << |
实验方案
技术信息
CAS号 | 107753-78-6 | 储存条件 |
|
|||||||||||||
分子式 | C31H33N3O6S | 运输 | 蓝冰 | |||||||||||||
分子量 | 575.68 | 别名 | ICI 204219;ICI-204,219;brand names Accolate;Accoleit;and Vanticon;扎鲁司特 | |||||||||||||
溶解度 |
|
动物实验配方 |
|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01125748 | Allergic Asthma | Phase 4 | Completed | - | - |
NCT01125748 | - | - | Completed | - | - |
NCT01283061 | Healthy | Phase 1 | Completed | - | India ... more >> BA Research India Ltd. Ahmedabad, Bodakdev, India, 380 054 Collapse << |
NCT02950480 | Breast Cancer | Phase 2 | Recruiting | January 2020 | United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143-1711 Contact: Pamela N. Munster, MD 877-827-3222 cancertrials@ucsf.edu Collapse << |
靶点 | Description | IC50 |
---|
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网